Incidence of Interstitial Lung Disease (ILD) in Users of ACTEMRA® (Tocilizumab), Rituxan® (Rituximab), Abatacept and Anti-Tumor Necrosis Factor Alpha Agents

Documents

Study protocol

Study results

Study report

Other information

Publications

Study publications

Curtis JR, Sarsour K, Napalkov P, Costa LA, Schulman KL. Incidence and complica…